Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29499151.
- Also identified by DOI 10.1016/j.stem.2018.02.011 and PMC identifier 5837068.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Organs-on-a-chip (OOCs) are miniature tissues and organs grown in vitro that enable modeling of human physiology and disease. The technology has emerged from converging advances in tissue engineering, semiconductor fabrication, and human cell sourcing. Encompassing innovations in human stem cell technology, OOCs offer a promising approach to emulate human patho/physiology in vitro, and address limitations of current cell and animal models. Here, we review the design considerations for single and multi-organ OOCs, discuss remaining challenges, and highlight the potential impact of OOCs as a fast-track opportunity for tissue engineering to advance drug development and precision medicine.
Medical subject headings
- Drug Development
- Lab-On-A-Chip Devices
- Tissue Engineering